Cited by 888Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.

Diabetic dyslipidaemia: from basic research to clinical practice*

Open access

Taskinen, M.-R.·2003·Diabetologia

DOI 10.1007/s00125-003-1111-y

Open this paper in CoChat — free account Open PDF

Abstract

The recognition that the increase of plasma triglyceride rich lipoproteins (TRLs) is associated with multiple alterations of other lipoproteins species that are potentially atherogenic has expanded the picture of diabetic dyslipidaemia. The discovery of heterogeneity within major lipoprotein classes VLDL, LDL and HDL opened new avenues to reveal the specific pertubations of diabetic dyslipidaemia. The increase of large VLDL 1 particles in Type 2 diabetes initiates a sequence of events that generates atherogenic remnants, small dense LDL and small dense HDL particles. Together these components comprise the atherogenic lipid triad. Notably the malignant nature of diabetic dyslipidaemia is not completely shown by the lipid measures used in clinical practice. The key question is what are the mechanisms behind the increase of VLDL 1 particles in diabetic dyslipidaemia? Despite the advances of recent years, our understanding of VLDL assembly and secretion is still surprisingly incomplete. To date it is still unclear how the liver is able to regulate the amount of triglycerides incorporated into VLDL particles to produce either VLDL 1 or VLDL 2 particles. The current evidence suggests that the machinery driving VLDL assembly in the liver includes (i) low insulin signalling via PI-3 kinase pathway that enhances lipid accumulation into "nascent " VLDL particles (ii) up-regulation of SREBP-1C that stimulates de novo lipogenesis and (iii) excess availability of "polar molecules" in hepatocytes that stabilizes apo B 100. Recent data suggest that all these steps could be fundamentally altered in Type 2 diabetes explaining the overproduction of VLDL apo B as well as the ability of insulin to suppress VLDL 1 apo B production in Type 2 diabetes. Recent discoveries have established the transcription factors including PPARs, SREBP-1 and LXRs as the key regulators of lipid assembly in the liver. These observations suggest these factors as a new target to tailor more efficient drugs to treat diabetic dyslipidaemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-003-1111-y

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Self-citation
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014

Show all 183 references

Sorted by citations

Items 301–400 of 885

Unwinding Complexities of Diabetic Alzheimer by Potent Novel Molecules
Gupta, S., Nair, A. B., Jhawat, V., Mustaq, N., Sharma, A., Dhanawat, M., & Khan, S. A. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520937542 · Cited by 33
Post-prandial triglyceride profile in a population-based sample of Type 2 diabetic patients
Iovine, C., Vaccaro, O., Gentile, A., Romano, G., Pisanti, F. A., Riccardi, G., & Rivellese, A. A. (2004) · Diabetologia · doi:10.1007/s00125-003-1269-3 · Cited by 31
Fixed-Dose Combination Fenofibrate/Pravastatin 160/40 mg Versus Simvastatin 20 mg Monotherapy in Adults With Type 2 Diabetes and Mixed Hyperlipidemia Uncontrolled With Simvastatin 20 mg: A Double-Blind, Randomized Comparative Study
Farnier, M., Steinmetz, A., Retterstøl, K., & Császár, A. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.02.006 · Cited by 30
The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes
Gonna, H., & Ray, K. K. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13691 · Cited by 30
Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes
Hendawy, O. M., El‐Naggar, M. E., El-Banna, M., Fouda, M. M. G., Othman, S. I., Allam, A. A., & Morsy, O. M. (2020) · Investigational New Drugs · doi:10.1007/s10637-020-00905-6 · Cited by 30
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes
Taskinen, M., Björnson, E., Kahri, J., Söderlund, S., Matikainen, N., Porthan, K., Ainola, M., Hakkarainen, A., Lundbom, N. M. I., Fermanelli, V., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315446 · Cited by 31
Self-citation
Aloe vera in diabetic dyslipidemia: Improving blood glucose and lipoprotein levels in pre-clinical and clinical studies
Deora, N., & Venkatraman, K. (2022) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2022.100675 · Cited by 39
Lipids and lipoprotein ratios: Contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitus
SHAH, A. S., Urbina, E. M., Khoury, P. R., Kimball, T. R., & Dolan, L. M. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.05.002 · Cited by 30
Nuclear magnetic resonance–determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus
Ding, S.-Y., Tigno, X. T., & HANSEN, B. C. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.015 · Cited by 30
Pharmacotherapy of Diabetes: New Developments
Mogensen, C. E. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6 · Cited by 30
Pharmacological management of diabetic dyslipidemia
Filippatos, T. D., Florentin, M., Georgoula, M., & Elisaf, M. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1263565 · Cited by 29
Pre-Meal Effect of Whey Proteins on Metabolic Parameters in Subjects with and without Type 2 Diabetes: A Randomized, Crossover Trial
Bjørnshave, A., Hermansen, K., & Holst, J. J. (2018) · Nutrients · doi:10.3390/nu10020122 · Cited by 29
Effects of rosiglitazone on postprandial leukocytes and cytokines in type 2 diabetes
van Wijk, J. P. H., Cabezas, M. C., Coll, B., Joven, J., Rabelink, T. J., & de Koning, E. J. P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.07.001 · Cited by 30
Multimodal imaging of biological tissues using combined MALDI and NAPA-LDI mass spectrometry for enhanced molecular coverage
Fincher, J. A., Korte, A. R., Yadavilli, S., Morris, N. J., & Vértes, Á. (2020) · The Analyst · doi:10.1039/d0an00836b · Cited by 30
Association of serum apolipoprotein B48 level with the presence of carotid plaque in type 2 diabetes mellitus
Tanimura, K., Nakajima, Y., Nagao, M., Ishizaki, A., Kano, T., Harada, T., Okajima, F., Sudo, M., Tamura, H., Ishii, S., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.028 · Cited by 27
Effect of sitagliptin on energy metabolism and brown adipose tissue in overweight individuals with prediabetes: a randomised placebo-controlled trial
Nahon, K. J., Doornink, F., Straat, M. E., Botani, K., Martínez‐Téllez, B., Abreu-Vieira, G., van Klinken, J. B., Voortman, G. J., Friesema, E. C. H., Ruiz, J. R., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4716-x · Cited by 28
Postprandial dyslipidaemia and diabetes
Pang, J., Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328354c790 · Cited by 29
SHP-2 and PI3-kinase genes PTPN11 and PIK3R1 may influence serum apoB and LDL cholesterol levels in normal women
Jamshidi, Y., Gooljar, S. B., Snieder, H., Wang, X., Ge, D., Swaminathan, R., Spector, T. D., & O’Dell, S. D. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.013 · Cited by 28
“Mild dysglycemia” in type 2 diabetes: to be neglected or not?
Monnier, L., Colette, C., Dejager, S., & Owens, D. R. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.004 · Cited by 28
Fatty acid-induced atherogenic changes in extracellular matrix proteoglycans
Rodrı́guez-Lee, M., Bondjers, G., & Camejo, G. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ef534f · Cited by 27
Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes
Chaudhuri, A., & Dandona, P. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01423.x · Cited by 28
Apolipoproteins AI and B as therapeutic targets
Charlton-Menys, V., & Durrington, P. N. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01646.x · Cited by 28
Diabetic dyslipidaemia: insights for optimizing patient management
Vergès, B. L. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x36468 · Cited by 28
Triterpenoid-Rich Fraction from Ilex hainanensis Merr. Attenuates Non-Alcoholic Fatty Liver Disease Induced by High Fat Diet in Rats
Cui, W., Yang, J., Chen, X.-Q., Mao, Q., Wei, X., Wen, X., & Wang, Q. (2013) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x13500353 · Cited by 27
Mass spectrometry imaging of triglycerides in biological tissues by laser desorption ionization from silicon nanopost arrays
Fincher, J. A., Korte, A. R., Dyer, J. E., Yadavilli, S., Morris, N. J., Jones, D. R., Shanmugam, V. K., Pirlo, R. K., & Vértes, Á. (2019) · Journal of Mass Spectrometry · doi:10.1002/jms.4443 · Cited by 28
Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice
Adachi, H., Kondo, T., Koh, G. Y., Nagy, A., Oike, Y., & Araki, E. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.110 · Cited by 27
Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus
Dullaart, R. P. F., de Vries, R., Dallinga‐Thie, G. M., van Tol, A., & Sluiter, W. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.11.003 · Cited by 27
Catabolism of lipoproteins and metabolic syndrome
Thérond, P. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832c5a12 · Cited by 27
Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone
Ronsein, G. E., Reyes‐Soffer, G., He, Y., Oda, M. N., Ginsberg, H. N., & Heinecke, J. W. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.054528 · Cited by 27
LDL particle subspecies are distinct in their capacity to mediate free cholesterol efflux via the SR-BI/Cla-1 receptor
Tréguier, M., Moreau, M., Sposito, A. C., Chapman, M. J., & Huby, T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.12.004 · Cited by 27
Microglial SCAP deficiency protects against diabetes-associated cognitive impairment through inhibiting NLRP3 inflammasome-mediated neuroinflammation
Zhu, W., Zhang, H., Niu, T., Liu, K., Farooqui, H. F. M., Sun, R., Chen, X., Yuan, Y., & Wang, S. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.051 · Cited by 28
Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: A multicenter, large sample survey
Li, B., Liu, Y., Zhou, X. J., Chen, L., Yan, L., Tang, X., Gao, Z., Wan, Q., Luo, Z., Qin, G., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13592 · Cited by 27
Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease
Russo, G. T., Giandalia, A., Romeo, E. L., Marotta, M., Alibrandi, A., Francesco, C. D., Horvath, K. V., Asztalos, B. F., & Cucinotta, D. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0023-z · Cited by 26
Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes
Vergès, B. L., Florentin, E., Baillot-Rudoni, S., Monier, S., Petit, J., Rageot, D., Gambert, P., & Duvillard, L. (2008) · Diabetologia · doi:10.1007/s00125-008-1046-4 · Cited by 26
Strategies for Modifying High-Density Lipoprotein Cholesterol: A Role for Nicotinic Acid
Schächter, M. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-5685-0 · Cited by 27
Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults
Zheng, S., Tingting, H., Xu, H., Zhou, H., Ren, X., Wu, P., Zheng, J., Wang, L., Zhang, M., Jiang, Y., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014038 · Cited by 26
Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: Role of kidney dysfunction
Zoppini, G., Targher, G., Negri, C., Stoico, V., Gemma, M. L., & Bonora, E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.035 · Cited by 24
In VivoEvidence of Impaired Peripheral Fatty Acid Trapping in Patients with Human Immunodeficiency Virus-Associated Lipodystrophy
van Wijk, J. P. H., Cabezas, M. C., de Koning, E. J. P., Rabelink, T. J., van der Geest, R. J., & Hoepelman, I. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2343 · Cited by 26
Dissociation between the Insulin-Sensitizing Effect of Rosiglitazone and Its Effect on Hepatic and Intestinal Lipoprotein Production
Duez, H., Lamarche, B., Uffelman, K. D., Valéro, R., Szeto, L., Lemieux, S., Cohn, J. S., & Lewis, G. F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2110 · Cited by 26
Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans
Hieronimus, B., Griffen, S. C., Keim, N. L., Bremer, A. A., Berglund, L., Nakajima, K., Havel, P. J., & Stanhope, K. L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070913 · Cited by 26
Managing dyslipidemia in patients with Type 2 diabetes
Tomlinson, B., Patil, N. G., Fok, M., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1912734 · Cited by 25
Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol
Hirano, T., Kodera, R., Hirashima, T., Suzuki, N., Aoki, E., Hosoya, M., Oshima, T., Hayashi, T., Koba, S., Ohta, M., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.62789 · Cited by 28
The effects of ginger and its constituents in the prevention of metabolic syndrome: A review.
Salaramoli, S., Mehri, S., Yarmohammadi, F., Hashemy, S. I., & Hosseinzadeh, H. (2022) · PubMed · doi:10.22038/ijbms.2022.59627.13231 · Cited by 30
Promising influences of gingerols against metabolic syndrome: A mechanistic review
Alipour, A., Rahimi, V. B., & Askari, V. R. (2022) · BioFactors · doi:10.1002/biof.1892 · Cited by 25
Association of cumulative monocyte to high-density lipoprotein ratio with the risk of type 2 diabetes: a prospective cohort study
Wu, D., Lan, Y., Xu, Y., Xu, S., Huang, Y., Balmer, L. A., Mahara, G., Xu, W., Wang, W., & Wu, S. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01701-7 · Cited by 26
The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond
Chen, D.-Q., Xie, Y., Cao, L.-Q., Fleishman, J. S., Chen, Y., Wu, T., & Yang, D. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101062 · Cited by 25
Dyslipidemia in children with type 2 diabetes vs. obesity
Newfield, R. S., Dewan, A. K., & Jain, S. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00345.x · Cited by 25
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Tonkin, A. M., Hunt, D., Voysey, M., Kesäniemi, A., Hamer, A. W., Waites, J. H., Mahar, L., Mann, S., Glasziou, P., Forder, P., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2011.12.004 · Cited by 25
Lotus leaf alleviates hyperglycemia and dyslipidemia in animal model of diabetes mellitus
Kim, A.-R., Jeong, S.-M., Kang, M., Jang, Y.-H., Choi, H., & Kim, J.-I. (2013) · Nutrition Research and Practice · doi:10.4162/nrp.2013.7.3.166 · Cited by 25
Association Analysis of Dyslipidemia-Related Genes in Diabetic Nephropathy
McKay, G. J., Savage, D. A., Patterson, C., Lewis, G. A., McKnight, A. J., Maxwell, A. P., & the Warren 3/UK GoKinD Study Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0058472 · Cited by 25
Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus
Mulder, D. J., de Boer, J. F., Graaff, R., de Vries, R., Annema, W., Lefrandt, J. D., Smit, A. J., Tietge, U. J. F., & Dullaart, R. P. F. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.011 · Cited by 25
Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes
Russo, G. T., Giandalia, A., Romeo, E. L., Alibrandi, A., Horvath, K. V., Asztalos, B. F., & Cucinotta, D. (2014) · International Journal of Endocrinology · doi:10.1155/2014/607924 · Cited by 25
Enteroendocrine cells and lipid absorption
Mellitzer, G., & Gradwohl, G. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834622a2 · Cited by 28
Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes
Calderon, R. M., Navas‐Acién, A., Escolar, E., Nathan, D. M., Newman, J. D., Schmedtje, J. F., Diaz, D., Lamas, G. A., & Fonseca, V. A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01484 · Cited by 25
Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels
Hieshima, K., Sugiyama, S., Yoshida, A., Kurinami, N., Suzuki, T., Ijima, H., MIYAMOTO, F., Kajiwara, K., Jinnouchi, K., Jinnouchi, T., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13191 · Cited by 25
Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
Matikainen, N., & Taskinen, M. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0309-3 · Cited by 24
Self-citation
Nutritional Supplementation with Essential Amino Acids and Phytosterols May Reduce Risk for Metabolic Syndrome and Cardiovascular Disease in Overweight Individuals with Mild Hyperlipidemia.
Coker, R. H., Deutz, N. E. P., Schutzler, S. E., Beggs, M. L., Miller, S. L., Wolfe, R. R., & Wei, J. Y. (2015) · PubMed · Cited by 24
NADPH oxidase 2 plays a critical role in dysfunction and apoptosis of pancreatic β-cells induced by very low-density lipoprotein
Jiao, J., Dou, L., Li, M., Lu, Y., Guo, H., Man, Y., Wang, S., & Li, J. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1402-z · Cited by 24
Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus
Dullaart, R. P. F., de Vries, R., & Lefrandt, J. D. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.08.008 · Cited by 24
Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
Voukali, M., Kastrinelli, I., Stragalinou, S., Tasiopoulou, D., Paraskevopoulou, P., Katsilambros, N., Kokkinos, A. D., Tentolouris, N., & Ioannidis, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/304032 · Cited by 26
RETRACTED: A novel sensor to estimate the prevalence of hypochlorous (HOCl) toxicity in individuals with type 2 diabetes and dyslipidemia
Ghoshal, K., Das, S., Aich, K., Goswami, S., Chowdhury, S., & Bhattacharyya, M. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.006 · Cited by 24
Retracted
Hypolipidaemic function of Hsian-tsao tea ( Mesona procumbens Hemsl.): Working mechanisms and active components
Huang, H., Chuang, S., Wu, Y.-C., & Chao, P. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.07.019 · Cited by 24
High Plasma Concentration of Remnant Lipoprotein Cholesterol in Obese Children and Adolescents
Choi, Y. J., Jo, Y. E., Kim, Y. K., Ahn, S. M., Jung, S. H., Kim, H. J., Chung, Y., Lee, K. W., & Kim, D. J. (2006) · Diabetes Care · doi:10.2337/dc06-0938 · Cited by 24
Managing diabetic dyslipidemia: Beyond statin therapy
Neeli, H., Gadi, R., & Rader, D. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0004-y · Cited by 22
Niaspan®: creating a new concept for raising HDL-cholesterol
McGovern, M. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui042 · Cited by 24
Microsomal Triglyceride Transfer Protein: From Lipid Metabolism to Metabolic Diseases
Iqbal, J., Jahangir, Z., & Qarni, A. A. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_4 · Cited by 24
Performance of Radiomics Models Based on Coronary Computed Tomography Angiography in Predicting The Risk of Major Adverse Cardiovascular Events Within 3 Years: A Comparison Between the Pericoronary Adipose Tissue Model and the Epicardial Adipose Tissue Model.
You, H.-R., Zhang, R.-R., Hu, J., Sun, Y., Li, X.-G., Hou, J., Pei, Y.-S., Zhao, L.-L., Zhang, L.-B., & Yang, B. (2022) · Academic Radiology · doi:10.1016/j.acra.2022.03.015 · Cited by 22
Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARγ agonist
Badeau, R. M., Honka, M., Läutamaki, R., Stewart, M. W., Kangas, A. J., Soininen, P., Ala‐Korpela, M., & Nuutila, P. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.853369 · Cited by 23
Dyslipidemia among diabetic patients in Southern Ethiopia: Cross-sectional study
Ambachew, H., Shimelis, T., & Lemma, K. (2015) · Journal of Diabetes and Endocrinology · doi:10.5897/jde2015.0086 · Cited by 23
Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials
Allemann, S., Diem, P., Egger, M., Christ, E., & Stettler, C. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x89865 · Cited by 23
American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes – 2026 Update
Samson, S. L., Vellanki, P., Blonde, L., Hirsch, I. B., Hoang, T. D., Isaacs, S. D., Izuora, K. E., Wang, C. C. L., Ooi, C. P., Padilla, B. I., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.01.006 · Cited by 29
Umbelliferone ameliorates oxidative stress and testicular injury, improves steroidogenesis and upregulates peroxisome proliferator-activated receptor gamma in type 2 diabetic rats
Allam, M. A. M., Khowailed, A. A., Elattar, S., & Mahmoud, A. M. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab083 · Cited by 22
Comparison of effect of resveratrol and vanadium on diabetes related dyslipidemia and hyperglycemia in streptozotocin induced diabetic rats
Mohammadshahi, M., Haidari, F., & Shiri, M. (2011) · Europe PMC (PubMed Central) · doi:10.5681/apb.2011.012 · Cited by 22
Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets
Kappelle, P. J. W. H., Dallinga‐Thie, G. M., & Dullaart, R. P. F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.021 · Cited by 22
Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study
Martínez‐Hervás, S., Carmena, R., Ascaso, J. F., Real, J. T., Masana, L., Catalá, M. A., Vendrell, J. J., Vázquez, J. A., Valdés, S., Urrutia, I., et al. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2013.12.001 · Cited by 21
Periodontitis contributes to aberrant metabolism in type 2 diabetes mellitus rats by stimulating the expression of adipokines
Luo, S.-K., Yang, X., Wang, D., Ni, J., Wu, J., Zhao, X. D., Xuan, D., & Zhang, J. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12322 · Cited by 22
PCSK9 and resistin at the crossroads of the atherogenic dyslipidemia
Rashid, S., & Kastelein, J. J. P. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.839204 · Cited by 24
Agreement Between Fasting and Postprandial LDL Cholesterol Measured with 3 Methods in Patients with Type 2 Diabetes Mellitus
Lund, S. S., Petersen, M., Frandsen, M., Smidt, U., Parving, H., Vaag, A. A., & Jensen, T. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.133868 · Cited by 22
Abresham ameliorates dyslipidemia, hepatic steatosis and hypertension in high-fat diet fed rats by repressing oxidative stress, TNF-α and normalizing NO production
Nepal, S., Malik, S., Sharma, A. K., Bharti, S., Kumar, N., Siddiqui, K. M., Bhatia, J., Kumari, S., & Arya, D. S. (2011) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2011.01.003 · Cited by 21
Long-term exposure to outdoor air pollution and risk factors for cardiovascular disease within a cohort of older men in Perth
Hoorn, S. V., Murray, K., Nedkoff, L., Hankey, G. J., Flicker, L. A., Yeap, B. B., Almeida, O. P., Norman, P. E., Brunekreef, B., Nieuwenhuijsen, M. J., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248931 · Cited by 21
Comparisons of the Relationships Between Multiple Lipid Indices and Diabetic Kidney Disease in Patients With Type 2 Diabetes: A Cross-Sectional Study
Lu, C., Liu, W., Chen, Z., Hua, L.-Y., Wang, X., & Huang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.888599 · Cited by 23
Remnant Cholesterol Is Associated With Gestational Diabetes Mellitus: A Cohort Study
Wang, W., Li, N., Wang, X., Zhang, X., Tu, M., Lin, L., Li, Q., Zhang, H., Liu, J., Yang, X., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad262 · Cited by 21
Triglyceride/HDL cholesterol ratio and lipoprotein insulin resistance Score: Associations with subclinical atherosclerosis and incident cardiovascular disease
Flores-Guerrero, J. L., Been, R. A., SHALAUROVA, I. Y., Connelly, M. A., van Dijk, P. R., & Dullaart, R. P. F. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117737 · Cited by 21
Variations in erythrocyte antioxidant levels and lipid peroxidation status and in serum lipid profile parameters in relation to blood haemoglobin A1c values in individuals with type 2 diabetes mellitus
Thangaraj, A., Vasanthakumar, A., Geraldine, P., & Thomas, P. A. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.018 · Cited by 21
The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
Thomas, M. C., Jandeleit-Dahm, K. A. M., & Tikellis, C. (2012) · PPAR Research · doi:10.1155/2012/456529 · Cited by 22
Hepatitis C and hepatic steatosis
Patel, J. H., Cobbold, J., Thomas, H. C., & Taylor-Robinson, S. D. (2010) · QJM · doi:10.1093/qjmed/hcp192 · Cited by 21
Effects of one single bout of low-intensity exercise on postprandial lipaemia in type 2 diabetic men
Dalgaard, M., Thomsen, C., & Hermansen, K. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20041227 · Cited by 21
Lipid Profile in Childhood-and Youth-Onset Type 2 Diabetes and their Association with Microvascular Complications.
Amutha, A., Pradeepa, R., Chella, K. S., Anjana, R. M., Ranjit Unnikrishnan, I., & Mohan, V. (2017) · PubMed · Cited by 21
Fasting and postprandial lipid parameters: A comparative evaluation of cardiovascular risk assessment in prediabetes and diabetes
Chakraborty, M., Singh, P., D’souza, J. M. P., Pethusamy, K., & Thatkar, P. V. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_769_19 · Cited by 20
Danning tablets alleviate high fat diet-induced obesity and fatty liver in mice via modulating SREBP pathway
Ma, Y., Li, J., Ju, Z., Huang, W., Wang, Z., Yang, L., & Ding, L. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114320 · Cited by 20
Metabolism of Triglyceride-Rich Lipoproteins
Borén, J., & Taskinen, M. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_520 · Cited by 22
Self-citation
Triglyceride Metabolism Modifies Lipoprotein(a) Plasma Concentration
Ramos-Cáceres, M., Lamíquiz-Moneo, I., Cenarro, A., Calmarza, P., Marco-Benedí, V., Bea, A. M., Mateo‐Gállego, R., Puzo, J., Ordovás, J. M., Civeira, F., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac412 · Cited by 19
Hypertriglyceridemia and Atherosclerotic Carotid Artery Stenosis
Miura, Y., & Suzuki, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416224 · Cited by 21
Efficacy and safety of PCSK9 inhibitors in patients with diabetes: A systematic review and meta-analysis
Chen, T., Wang, Z., Xie, J., Xiao, S., Li, W., & Liu, N. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.05.033 · Cited by 20
Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis
Soffientini, U., Caridis, A.-M., Dolan, S., & Graham, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.002 · Cited by 20
A placebo‐controlled proof‐of‐concept study of alirocumab on postprandial lipids and vascular elasticity in insulin‐treated patients with type 2 diabetes mellitus
Burggraaf, B., Pouw, N. M. C., Fernández‐Arroyo, S., der Zee, L. C. V. V., van de Geijn, G. M., Birnie, E., Huisbrink, J., van der Zwan, E. M., Mulder, M. T., Rensen, P. C. N., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13960 · Cited by 21
The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?
Rizzo, M., Christ, E., Rini, G. B., Spinas, G. A., & Berneis, K. K. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.13.2295 · Cited by 19
Mean postprandial triglyceride concentration is an independent risk factor for carotid atherosclerosis in patients with type 2 diabetes
Idei, M., Hirayama, S., Miyake, N., Kon, M., Horiuchi, Y., Ueno, T., Miyake, K., Satoh, N., Yoshii, H., Yamashiro, K., et al. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.12.022 · Cited by 20
Multi-level analysis reveals the association between diabetes, body mass index, and HbA1c in an Iraqi population
Kowsar, R., & Mansouri, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-25813-y · Cited by 14
Impact of triglycerides on lipid and lipoprotein biology in women
Dayspring, T. D., & Pokrywka, G. S. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.05.002 · Cited by 19

Authors: Taskinen, M.-R.
Affiliations: University of Helsinki (FI)
Corresponding author: Taskinen, M.-R.
ORCID: Taskinen, M.-R.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2003-06-01
Volume: 46
Issue: 6
Pages: 733-749
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-003-1111-y
OpenAlex: W2020659754
Cited by: 888
References: 183
Citations by year: 2026: 27 · 2025: 37 · 2024: 32 · 2023: 36 · 2022: 48 · 2021: 41 · 2020: 39 · 2019: 27 · 2018: 32 · 2017: 28 · 2016: 29 · 2015: 47 · 2014: 41 · 2013: 46 · 2012: 42
FWCI: 6.10
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Academy of Finland
Diabetesliitto
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: diabetic dyslipidemia, type 2 diabetes, small dense LDL, triglyceride-rich lipoproteins, VLDL assembly, hepatic lipid metabolism, insulin signaling, PI3-kinase, SREBP-1c, de novo lipogenesis, apolipoprotein B-100, peroxisome proliferator-activated receptors, SREBP1, liver X receptor
MeSH terms: Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Diabetes Complications, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetic dyslipidaemia: from basic research to clinical practice*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks